Figure 4
From: Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
(A,B) Overall and disease-free survival curves according to the number of fascin-immunoreactive tumour cells (A) and immunostaining intensity (B) in both adenocarcinomas and epidermoid or squamous cell carcinomas.
